Brief: Precigen Pipeline Updates to be Presented at 42nd Annual J.P. Morgan Healthcare Conf
08/01/2024 17:42
Jan 8 (Reuters) - Precigen Inc PGEN.O :
* PRECIGEN INC: PRGN-2012 PHASE 2 PIVOTAL STUDY DATA IN RRP
IS
ANTICIPATED IN Q2 OF 2024
Source text for Eikon: ID:nPn7kqhYHa
Further company coverage: PGEN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Precigen
See all newsBrief: Precigen Receives FDA Platform Technology Designation For Adenoverse Platform
Precigen, Inc. reports results for the quarter ended June 30 - Earnings Summary
Precigen posts quarterly profit as PAPZIMEOS sales surge
Precigen Inc expected to post a loss of 1 cent a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Advanced Energy, Bel Fuse, Cerebras